Trailing-twelve-month (TTM) revenue is $963.18 Million with a year-over-year growth of (3.10%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $245,918,841 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $240,142,444 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-06 |
| Q1 FY2026Period ended 2026-03-31 | $235,996,234 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $241,118,645 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $963,176,164 |
Current P/S: $670,218,317 market capitalization ÷ $963,176,164 TTM revenue = 0.70x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $241.12M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:21:14.188Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD |
|---|---|---|---|---|---|---|
| Commercial Lines Segment | N/A | N/A | N/A | N/A | N/A | $540M |
| Personal Lines Segment | N/A |
$963.18M
$963.18 Million
(3.10%)
vs. $993.99M a year ago (TTM)
+3.86%
5 Year compound annual growth rate
1 Year
(3.10%)
3 Year
+2.66%
5 Year
+3.86%
10 Year
+3.87%
15 Year
+5.39%
20 Year
+5.58%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $978.01M | ($11.59M) | (1.17%) |
| 2024 | $989.61M | +$62.27M | +6.71% |
| 2023 | $927.34M | +$79.12M | +9.33% |
| 2022 | $848.22M | +$31.75M | +3.89% |
| 2021 | $816.47M | +$38.65M | +4.97% |
| 2020 |
TTM Growth
(3.10%)
3-Year CAGR
+2.66%
5-Year CAGR
+3.86%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| N/A |
| N/A |
| N/A |
| $397M |
| Property and Casualty, Commercial Insurance | N/A | N/A | $468M | $510M | $533M | N/A |
|---|
| Property and Casualty, Commercial Insurance Product Line | $385M | $413M | N/A | N/A | N/A | N/A |
|---|
| Property and Casualty, Personal Insurance | N/A | N/A | $308M | $312M | $349M | N/A |
|---|
| Property and Casualty, Personal Insurance Product Line | $371M | $329M | N/A | N/A | N/A | N/A |
|---|
| $777.82M |
| ($34.34M) |
| (4.23%) |
| 2019 | $812.16M | +$43.02M | +5.59% |
| 2018 | $769.13M | +$31.73M | +4.30% |
| 2017 | $737.40M | +$50.07M | +7.28% |
| 2016 | $687.34M | +$52.23M | +8.22% |
